Product Name | Protease - Activated Receptor - 1, PAR - 1 Agonist, amideTFLLRNPNDK - NH2 |
Size | 1 mg |
Catalog # | AS-62936 |
US$ | $68 |
Purity | % Peak Area By HPLC ≥ 95% |
This peptide is a thrombin receptor activating peptide. This PAR-1 agonist peptide reversibly binds to PAR-1 mimicking the "tethered ligand" that thrombin makes available through proteolytic cleavage of substrate.It is also known to cause increase in liquid and protein permeability much like thrombin. | |
Detailed Information | Material Safety Data Sheets (MSDS) |
Storage | -20°C |
References | Vogel, SM. et al. Physiol. Genom. 4:137-145 (2000). |
Molecular Weight | 1216.4 |
TFLLRNPNDK-NH2 | |
Sequence(Three-Letter Code) | H - Thr - Phe - Leu - Leu - Arg - Asn - Pro - Asn - Asp - Lys - NH2 |
Product Citations | Kouzaki, H. et al. (2013). Transcription of Interleukin-25 and extracellular release of the protein is regulated by allergen proteases in airway epithelial cells J. Resp. Cell. Mol. Biol49(5):741-750. doi:10.1165/rcmb.2012-0304OCMosnier, L. O. (2012). Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46 Blood doi: http://dx.doi.org/10.1182/blood-2012-08-452169. Wang, W. et al. (2009). Kallikrein-related peptidase-4 initiates tumor-stroma interactions in prostate cancer through protease-activated receptor-1. Int J Cancer126, 599. doi: 10.1002/ijc.24904. |